{"id":"tp-49864","type":"article-newspaper","title":"Edwards Lifesciences Lifts 2026 Constant-Currency Sales-Growth Outlook to About 11.5%","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/49864","datePublished":"2026-11-06T05:36:29.000Z","dateModified":"2026-11-06T05:36:29.000Z","language":"en","abstract":"The company also raised its TAVR growth range and projected TMTT sales of $780 million to $790 million.","section":"Business","references":[]}